Preparation of Modified-Release Tramadol Tablets and Drug Release Evaluation using Dependent and Independent Modeling Approaches

被引:0
作者
Aslam, Zartasha [1 ]
Akhter, Khalid P. [1 ]
Ahmad, Mahmood [2 ]
Aamir, Muhammad N. [3 ]
Naeem, Muhammad [1 ]
Ali, Muhammad Y. [4 ]
机构
[1] Islamia Univ Bahawalpur, Fac Sci, Dept Math, Bahawalpur, Pakistan
[2] Islamia Univ Bahawalpur, Fac Pharm & Alternat Med, Dept Pharm, Bahawalpur, Pakistan
[3] Univ Cent Punjab, Fac Pharm, Lahore, Pakistan
[4] GC Univ, Coll Pharm, Faisalabad, Pakistan
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2012年 / 31卷 / 10期
关键词
Model dependent and independent approaches; Modified release; Tramadol hydrochloride; FORMULATION; MATRICES;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Many attempts have been done in the preparation of modified-release preparations of Tramadol Hydrochloride (TH) to reduce the dose and the frequency of the dose during therapy. Trials on different polymeric systems are going on to get the required results. In present study ethyl cellulose (EC) and hydroxypropyl methylcellulose (HPMC) were used for the preparation of matrix tablets of tramadol hydrochloride, Six different formulations were prepared using different concentrations of these polymers. Effect of varying concentrations of EC and HPMC were observed on the modified release pattern of the matrices. Dissolution was performed in distilled water at 37.0 +/- 0.5 degrees C, while the stirring speed was set at 50 rpm. It was pragmatic that the formulations having low concentrations of either EC (25 or 50 mg) or HMPC (20 or 40 mg), more than 90 % drug was released during 12 hr. But when the concentrations of these polymers were increased less than 80 % of the drug was released from the matrix tablets during the said time (12 hr). The drug release behavior from formulations was evaluated using different kinetic models. It was obvious from these models that the most of the formulations followed the Higuchi square root model and the drug release mechanism was diffusion erosion. FDA similarity factor f(2) was also calculated form which paramount difference was observed among the formulations.
引用
收藏
页码:1417 / 1421
页数:5
相关论文
共 50 条
[41]   Development of controlled release dexketoprofen tablets and prediction of drug release using Artificial Neural Network (ANN) modelling [J].
Saracoglu, Ozlem Kislal ;
Uludag, Mecit Orhan ;
Ozdemir, Elif Derya ;
Degim, Ismail Tuncer .
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 56
[42]   A Semi-mechanistic Modeling Strategy to Link In Vitro and In Vivo Drug Release for Modified Release Formulations [J].
Martin Bergstrand ;
Erik Söderlind ;
Ulf G Eriksson ;
Werner Weitschies ;
Mats O Karlsson .
Pharmaceutical Research, 2012, 29 :695-706
[43]   A Semi-mechanistic Modeling Strategy to Link In Vitro and In Vivo Drug Release for Modified Release Formulations [J].
Bergstrand, Martin ;
Soderlind, Erik ;
Eriksson, Ulf G. ;
Weitschies, Werner ;
Karlsson, Mats O. .
PHARMACEUTICAL RESEARCH, 2012, 29 (03) :695-706
[44]   Formulation of a modified-release pregabalin tablet using hot-melt coating with glyceryl behenate [J].
Jeong, Kyu Ho ;
Woo, Hye Seung ;
Kim, Chae Jin ;
Lee, Kyung Hwa ;
Jeon, Jun Young ;
Lee, Sang Young ;
Kang, Jae-Hoon ;
Lee, Sangkil ;
Choi, Young Wook .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 495 (01) :1-8
[45]   FORMULATION AND CHARACTERIZATION OF MODIFIED RELEASE TABLETS CONTAINING ISONIAZID USING SWELLABLE POLYMERS [J].
Akhtar, M. F. ;
Rabbani, M. ;
Sharif, A. ;
Akhtar, B. ;
Saleem, A. ;
Murtaza, G. .
AFRICAN JOURNAL OF TRADITIONAL COMPLEMENTARY AND ALTERNATIVE MEDICINES, 2011, 8 (03) :250-259
[46]   New modified release tablets of bisoprolol fumarate for the treatment of hypertension: characterization and in vitro evaluation [J].
Panainte, Alina Diana ;
Gafitanu, Carmen ;
Stoleriu, Iulian ;
Tartau, Liliana Mititelu ;
Popescu, Maria-Cristina ;
Lisa, Gabriela ;
Popa, Eliza Gratiela .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2019, 50 :402-409
[47]   In-vitro and in-vivo characteristics of a modified-release double-pulse formulation for a water soluble drug [J].
Avramoff, A. ;
Domb, A. J. .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 (04) :250-258
[48]   Development and In Vitro Evaluation of Propranolol Hydrochloride Controlled Release Tablets Using HPMC as Matrix Former [J].
Villanova, Janaina C. O. ;
Consiglieri, Vladi O. .
LATIN AMERICAN JOURNAL OF PHARMACY, 2011, 30 (04) :729-736
[49]   Influence of Drug Property and Product Design on In Vitro-In Vivo Correlation of Complex Modified-Release Dosage Forms [J].
Qiu, Yihong ;
Li, Xia ;
Duan, John Z. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 103 (02) :507-516
[50]   Achieving a robust drug release from extended release tablets using an integrated continuous mixing and direct compression line [J].
Lakio, Satu ;
Tajarobi, Pirjo ;
Wikstrom, Hakan ;
Fransson, Magnus ;
Arnehed, Johan ;
Ervasti, Tuomas ;
Simonaho, Simo-Pekka ;
Ketolainen, Jarkko ;
Folestad, Staffan ;
Abrahmsen-Alami, Susanna .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 511 (01) :659-668